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Fish on Fluoxetine: Before, During, and After Behavioral Analysis Abstract
Chairperson: Allen Szalda-Petree
Chemical concentrations of antidepressants have increased over the years steadily
building in surface waters globally. These drugs have had various impacts on the animals tested,
such as impacts on movement, motivation, and reproduction. In order to further investigate the
effects of the antidepressant fluoxetine, male Betta splendens were exposed to the drug. These
fish are naturally aggressive for reproduction purposes and have easily observable aggressive
responses to other male fish. These characteristics make them a good model for studying
Fluoxetine’s impact on reproduction, motivation, and movement. Males in this study were
primed with either a female or empty chamber prior to choice testing trials. Choice testing trials
included ten daily trials, five with a mirror to study aggressive responding and another five that
served as a timeout condition. Latency and aggressive responding were measured for each trial
with video cameras used to record individual behavior. While no significant differences were
found for the preference for the mirror vs timeout condition, the fluoxetine did have a significant
impact on the fish latency and aggressive responding behavior. Results showed an increase in
latency and decrease in aggression when the fish were exposed to the drug. These results show
support for the hypothesis that Fluoxetine has an impact on motivation and movement in Betta
splendens.
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Worldwide Contamination
In recent years the scientific community has begun to focus on what happens when
pharmaceutical substances are released into the world via wastewater pollutants (Vymazal et al.,
2017). The release of these chemicals, or drugs, has earned them the title of pseudo-persistent
pollutants due to the constant, continued release of these chemicals into the environment
(Vymazal et al., 2017). While the concentration of these compounds may be low, the sheer
amount of chemicals mixing together has become a cause for concern, particularly since it is not
known if mixing them can cause a synergistic reaction (Vymazal et al., 2017). Furthermore, the
half-life of these chemicals varies greatly and not all are biodegradable, meaning they require
special circumstances to break down (Vymazal et al., 2017). This is highly concerning for
chemicals that are not biodegradable and known to be hazardous, because they are being released
directly into the environment in low concentrations and will have to degrade over time (Vymazal
et al., 2017).
It is estimated that approximately 20 to 30 percent of the chemicals in sewage from
human excretion are not filtered out and released into the world via wastewater (Logarinho et al.,
2016). Most chemicals, like psychoactive drugs, are not targeted by the filtration systems
currently in place in Water Waste Treatment Plants (WWTP), causing significant amounts of
these chemicals to be released back into the waterways (Wu et al., 2015; Borova et al., 2014).
Current methods for filtering out pharmaceuticals are not efficient, but the methods required for
total chemical removal are expensive and not economical (Koçolu, Bakirdere, and Keyf, 2017).
However, new methods are being developed that will help remove or breakdown chemicals at a
more economical price, such as using specific nanoparticles to target difficult compounds or
special salts that interrupt the ions of the drugs (Koçolu, Bakirdere, and Keyf, 2017; Basheer,
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2018). However, until these new methods have been tested and approved chemicals will continue
to be released unchecked all over the world (Borova et al., 2014).
Pharmaceuticals are entering waterways all over the world from the most populated cities
to the Artic Peninsula creating a global problem that will continue to grow if not addressed
(Borova et al., 2014; Mackul'Ak et al., 2016; González-Alonso et al., 2017). One point of entry
for a large amount of these chemicals is through hospital WWTP as many drugs pass through the
human system and into the sewage of these facilities (De Almeida et al., 2015). This could prove
hazardous when considering the large amount of chemicals administered and utilized in hospitals
worldwide. However, hospital WWTP’s are not the only contributor to the larger problem
worldwide. As more people start taking pharmaceuticals to help with illnesses, general
population sewage will see an increase in the level of contaminants (Subedi et al., 2013). Areas
with high populations are especially at risk for exposure to a high number of contaminants in
surface waters (Wu et al., 2015). Wu et al. (2015) found low concentrations of carbamazepine,
temazapam, diazepam, oxazepam, and alprazolam in tap water samples in China suggesting
surface water contamination of drinking water. However, Subedi et al. (2013) found that water is
not the only possible way of encountering the contaminants, as soil tests reveal high levels of soil
contamination from water deposits.
While it is encouraging that many researchers have focused on the concentrations and
causes behind the wastewater pollution in the environment, little is known about the overall
effects these chemicals have on the organisms inhabiting the contaminated water (Subedi et al.,
2013). Since water is necessary for life, all living things are affected by the release of chemicals
into the waterways, but marine organisms are forced to live in constant exposure to the pollutants
(Subedi et al., 2013). The continued release of the high variety of pharmaceuticals has caused
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concern for the fate of the marine organisms who live in the polluted environment, particularly
the smaller organisms who are necessary for healthy environmental function (Subedi et al.,
2013). While research in this department is limited, there are still some particularly striking
findings on the effect the polluted wastewater may be having on the marine world.
The amount of chemicals released into the water is increasing, and while methods for
extraction are currently in development, if left unchecked, these chemicals will continue to build
up in concentration and interact in unpredictable ways (Mackul'Ak et al., 2016). The most
common chemicals detected in the water sampled were mood stabilizers, stimulants, and
antidepressants (González-Alonso et al., 2017; Huerta-Fontela et al., 2008; Subedi and Kannan,
2015; Wu et al., 2015). Pharmaceuticals are prescribed to help a person recover or manage the
symptoms of a disease; however, with the release of these various drugs into the waterways these
chemicals are coming in contact with non-target organisms which could have unprecedented
effects on the behaviors of these organisms (Subedi et al., 2013). These chemicals can
bioconcentrate inside the organism, build up to higher concentrations in animal tissue than
surrounding water, and eventually some even achieve bioaccumulation, where the concentration
in the animal tissue is 5000 times more than in the surrounding water (Wang and Gardinali,
2013; De Solla et al., 2016). To check fish for chemical bioconcentration fish plasma, bile, and
gills are obtained from fish in surrounding waters (Tanoue et al., 2015). Some chemicals have
been shown to build up more rapidly, such as carbamazepine and ibuprofen, while others such as
caffeine have not been shown to bioconcentrate at all (Wang and Gardinali, 2013; Oetken et al.,
2005; Lahti et al., 2011; Ferrari et al., 2003; Garcia et al., 2012). This shows that the chemical
concentrations are variable and that some drugs may be more likely to build up in animal tissue
over time.
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While the buildup of these drugs in the animal system is concerning, the toxic or
behavioral effects on the wildlife could have consequences on the population and reproduction of
these organisms (Oetken et al., 2005; Lahti et al., 2011; Ferrari et al., 2003; Garcia et al., 2012).
Mood stabilizers have been shown to affect reproduction and boldness of fish, which is
dangerous for animals that are heavily preyed upon (Oetken et al., 2005; Lahti et al., 2011;
Ferrari et al., 2003; Garcia et al., 2012). Exposure to gestagens, birth control compounds, and
personal care products also impacts fish reproduction and causes developmental problems in fish
sexual characteristics (Fick et al., 2010; Miguel-Queralt and Hammond, 2008; Schebb et al.,
2011; Chen et al., 2008). Snails and bivalves are also vulnerable, and exposure to wastewater has
been reported to cause immunosuppression and inflammation of their tissues (Fong and Hoy,
2012; Gagné et al., 2006). In addition, antidepressant exposure negatively impacts the snail’s
ability to attach to soil, which impairs their movement and foraging abilities while leaving them
open to predation (Fong and Hoy, 2012; Gagné et al., 2006). These are only a small amount of
reported effects faced by aquatic wildlife, and without intervention the risk for more negative
consequences remains.
Of concern is the increasing amount of antidepressant and antianxiety medications
detected in surface waters, likely due to the rapidly increasing consumption by humans
(Mackul'Ak et al., 2016). These drugs have increased in consumption by 400 percent over the
last few decades, with the highest spikes in detection occurring in the winter months (Mackul'Ak
et al., 2016). There are a variety of drugs used to treat anxiety and depression, and they are
classified as beta blockers, SSRIs, anxiolytics, and benzodiazepines (Wick et al., 2009;
Mazzitelli et al., 2017). They work primarily with the serotonergic system, and sometimes the
dopaminergic system, affecting a variety of receptors in these areas of the brain (Fong and Hoy,
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2012). These systems are linked to many key behaviors like reproduction, swimming, and eating
in fish, bivalves, and annelids (Subedi et al., 2013). They have also been reported to have a
variety of effects related to both drug type, exposed species and drug concentration differences at
binding sites, such as γ-aminobutyric acid (GABA) receptors, which are widespread in aquatic
life (Chiffre et al., 2016; Brodin et al., 2013). Since these drugs are resistant to photodegradation
they are found in the environment and treated wastewater in concentrations between 0.01 to
several mg liter−1, creating a wide range of possible effects (Brodin et al., 2013).
The drugs used to treat anxiety and depression have shown a wide range of behavioral
impacts tied to both the dose and species, with each drug having various effects even on the same
species (Wick et al., 2009; Huggett et al., 2002; Brooks et al., 2005; Brooks et al., 2005; Fong,
Huminski, and D'Urso, 1998; Fong and Hoy, 2012; Minguez et al., 2014; Chiffre et al., 2016;
Mazzitelli et al., 2017; Brodin et al., 2013). Different drugs used to target the same system can
have various effects even at the same dosage which highlights the concerning aspects associated
with the drug cocktail mixtures that are released into the environment (Chiffre et al., 2016;
Mazzitelli et al., 2017; Brodin et al., 2013). If not removed multiple body systems could be
targeted simultaneously and affected by the cocktail mixture of chemicals (Chiffre et al., 2016;
Mazzitelli et al., 2017; Brodin et al., 2013). The wide variety of results from drugs targeting just
one body system, not even all the possible systems, shows the importance of drug contamination
removal (Koçolu, Bakirdere, and Keyf, 2017; Basheer, 2018).
One of the most common antidepressants, fluoxetine, has been found in waterways with
various concentrations all over the world (Brooks et al., 2005). This antidepressant has been
widely prescribed for humans by physicians and animals by veterinarians (Karagiannis, Burman,
and Mills, 2015). Like all anti-depressants this drug has become more common recently with
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spikes in consumption (Mackul'Ak et al., 2016). This increase in consumption in the last few
decades has made fluoxetine one of the more prevalent drugs in the wastewater effluent
(Mackul'Ak et al., 2016). This is causing concern among researchers due to the high potential of
fluoxetine to have a negative impact on critical animal behaviors (Clotfelter et al., 2007;
Dzieweczynski and Herbert, 2012; Eisenreich and Szalda-Petree, 2015; Eisenreich, Greene, and
Szalda-Petree, 2017; Snekser et al., 2006).
Fluoxetine
Fluoxetine is an SSRI prescribed to treat depression and acts on norepinephrine re-uptake
receptors, and nicotinergic acetylcholine receptors (Brooks et al., 2003). These receptors are
affected by the neurotransmitter serotonin (5-HT), and the drug works by interfering with the
reuptake at the presynaptic neuronal membranes (Brooks et al., 2005). After passing through the
human body, it is metabolized to norfluoxetine, which is also released into the environment
(Brooks et al., 2005). Fluoxetine is resistant to catabolic hydrolysis and photolysis and has a long
half-life of 100 or more days before breaking down completely (Mennigen et al., 2011). Of all
the SSRIs, fluoxetine is one of the most widely used in research on aquatic animals (Clotfelter et
al., 2007; Dzieweczynski and Herbert, 2012; Eisenreich and Szalda-Petree, 2015; Eisenreich,
Greene, and Szalda-Petree, 2017; Snekser et al., 2006).
Smaller aquatic animals are particularly vulnerable to even small increases in drug
concentrations as these smaller organisms can experience large effects on their behavior or even
succumb to toxicity (Brooks et al., 2003). This follows the bottom up approach, suggesting that
smaller organisms will be affected first and then the effects will spread up the food chain to
larger organisms (Brooks et al., 2003). Basically, if the algae are experiencing toxic effects
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causing a decrease in population, the organisms who eat the algae will be the first ones affected,
and the problem will continue to spread from there (Brooks et al., 2003).
Brooks et al. (2003) examined sensitivity to fluoxetine across a variety of aquatic
organisms. For this study they used, algae (Pseudokirchneriella subcapitata), Cladoceras
(Ceriodaphnia dubia and Daphnia magna), fish (Pimephales promelas and Oryias latipes), an
amphipod crustacean (Hyalella azteca), and a type of midge (Chironomus tentans) (Brooks et al.,
2003). The crustacean and midge were used as a way to test sediment toxicity, and all other
organisms were used for water toxicity (Brooks et al., 2003). At concentrations between 0.756 to
2.65 µM Ceriodaphnia dubia, Daphnia magna, and Pimephales promelas succumbed to toxicity,
and concentrations of 15.2 mg/kg proved toxic for Chironomus tentans (Brooks et al., 2003).
Fortunately for Oryias latipes and Hyalella azteca, no toxicity effects were found, though the
exact reason they were unaffected is unknown (Brooks et al., 2003). It was noted that the effect
on algae varied by age, with younger specimens of algae showing toxicity effects at lower
concentrations than older specimens (Brooks et al., 2003). This shows the importance of
considering both the species and age of the organism exposed to the drug, as each individual
species is different and reacts differently to drug exposure (Brooks et al., 2003).
Brooks et al. (2003) shows the importance of considering the drug’s effect on smaller
aquatic species like algae, but other small aquatic species are also vulnerable. Other popular
species used to study the effects of fluoxetine include clams, which are easy to obtain and
maintain in a laboratory setting (Fong, Huminski, and D'Urso, 1998). While algae are an
important prey species, clams fill a different role in the ecosystem, namely filtration (Fong,
Huminski, and D'Urso, 1998). Clams and snails have an interesting niche in waterways as they
filter the sediment, meaning they are exposed to chemicals through both the water and soil (Fong
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and Hoy, 2012; Gagné et al., 2006). Antidepressants have shown a wide effect on clams and
snails, impairing movement and reproduction thus putting these species at risk (Fong, Huminski,
and D'Urso, 1998; Fong and Hoy, 2012).
While fluoxetine is toxic to algae, a different reaction to antidepressants has been
recorded for clams (Clotfelter et al., 2007; Fong, Huminski, and D'Urso, 1998). Fong, Huminski,
and D'Urso (1998) tested the SSRIs fluvoxamine, fluoxetine, and paroxetine on the spawning
behavior of fingernail clams (Sphaerium striatinum). These drugs have been shown to trigger
birthing in clams by blocking the re-uptake transmitters at serotonergic synapses, causing
increased serotonin neurotransmissions (Fong, Huminski, and D'Urso, 1998). This has been
commonly used by laboratories to boost fingernail clam populations for research, but Fong,
Huminski, and D'Urso (1998) were interested in finding the minimum concentration to create
this effect. They found that concentrations as low as 100 pM to 100 µM for fluvoxamine, and 10
µM for paroxetine induced birthing in the clams, but these concentrations of fluoxetine had no
effect (Fong, Huminski, and D'Urso, 1998). These concentrations are much lower than those
typically used and have the ability to trigger birthing in clams (Fong, Huminski, and D'Urso,
1998). While antidepressants have been shown to decrease reproduction in fish, the clams show
the opposite effect, suggesting a wide range of effects from these drugs (Fong, Huminski, and
D'Urso, 1998).
Antidepressants clearly have effects on algae, snails, and clams which are important
small species in the ecosystem (Brooks et al., 2003; Fong, Huminski, and D'Urso, 1998; Fong
and Hoy, 2012). These species fill important roles in the environment and if disrupted this could
have large impacts on the ecosystem (Brooks et al., 2003; Fong, Huminski, and D'Urso, 1998;
Fong and Hoy, 2012). However, all aquatic species inhabiting the same water space are exposed
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to the same concentration of chemicals (Mackul'Ak et al., 2016). While it’s true that this problem
is following a bottom-up structure where smaller animals are likely to see the largest impacts,
animals of all species are at risk of chemical exposure (Mackul'Ak et al., 2016). This makes
work with fish both large and small important, especially since the fish will be getting exposure
through the surrounding water and food consumption (Mackul'Ak et al., 2016; Mennigen et al.,
2011).
Fish have also been shown to have more conservative binding sites in their hypothalamus
and telencephalon than mammals, which could lead to different ways of up-taking and disposing
of the drug (Mennigen et al., 2011). This makes fish an interesting model to consider for drug
research, which has revealed a variety of effects of Fluoxetine such as decreased aggression,
reproduction, and swimming behavior in some species, while simultaneously having the opposite
effect on other species (Eisenreich, Greene, and Szalda-Petree, 2017; Fong, Huminski, and
D'Urso, 1998; Mennigen et al., 2011). With the current amount of drug being dispensed into the
water, this makes research with marine life important to monitor the environmental impact longterm (Mackul'Ak et al., 2016).
Brooks et al. (2005) took to the field and collected specimens from a nearby stream to
examine the effects of fluoxetine and sertraline found in the environment. The researchers
collected three species of fish: bluegill (Lepomis macrochirus), channel catfish (Ictalurus
punctatus), and black crappie (Pomoxis nigromaculatus) from two separate streams in Texas,
one used to release wastewater and the other serving as a control stream (Brooks et al., 2005).
After dissection of the subjects to obtain brain, liver, and muscle tissues the researchers used gas
chromatography to check the concentration levels in each type of tissue (Brooks et al., 2005).
The highest concentrations were found in the brain tissues at 1.58 to 4.27 ng/g, and liver tissues
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at 1.34 to 3.59 ng/g of the fish caught in the contaminated stream, with lower concentrations in
the muscle tissues between 0.11 to 0.34 ng/g (Brooks et al., 2005). Overall, concentrations of
Sertraline were found to be higher than the Fluoxetine concentrations (Brooks et al., 2005).
However, the most disturbing finding is that the concentrations in the brain and liver tissues
exceeded the concentrations found in the surrounding waters, suggesting a slow buildup of the
drug over time, also known as bioconcentration (Brooks et al., 2005). Bioconcentration occurs
when the concentration of the drug is higher in a species tissues than in the surrounding waters,
and the amount of bioconcentration is measured by dividing the species concentration by the
concentration of the surrounding area (Brooks et al., 2005). This method has been used in fish
species to measure the buildup of drugs in the system over time, just like the results of Brooks et
al. (2005). Therefore, the researchers concluded that the fish had a higher bioconcentration than
the surrounding waters, and that the drug was accumulating in the fish systems faster than the
animals could metabolize it out (Brooks et al., 2005). This could be problematic for species that
live in water with concentrations close to their toxicity range, as buildup could push them past
that level (Brooks et al., 2003).
Another influential study conducted by Nakamura et al. (2008) on marine life using the
drug Fluoxetine focused on bioconcentration in relation to pH. The researchers reported the
highest concentrations of Fluoxetine at the time of the study were 0.012 lg 1-1 in streams of the
United States and were 0.099 lg 1-1 when wastewater was directly sampled (Nakamura et al.,
2008). While the drug is easily transported by soil and water it is possible that absorption of the
drug by dissolved organic matter would increase the speed of transport, and thus increase
bioaccumulation in the surrounding marine life (Nakamura et al., 2008).

FISH ON FLUOXETINE

11

Nakamura et al. (2008) used Japanese medaka to test the effect changes in pH would
have on Fluoxetine bioconcentrations in the fish. As noted earlier, pH affects the ionization of
drugs, and most are positive above a pH of 2.5, meaning a change in pH affects the stability of
most drugs (Borova et al., 2014). The impact on the ionization of the drug is important because
for ionization to occur an active transport system needs to present inside the animal for the drug
to move across the membrane (Borova et al., 2014; Nakamura et al., 2008). If the stability of the
drug is impacted, then the animal’s system may not be able to pass it through the membrane
(Borova et al., 2014; Nakamura et al., 2008).
To determine how bioconcentration levels were affected the fish were exposed to 300 lg
1-1 of fluoxetine and placed in one of three pH conditions: 7.2, 8.1, and 8.9 (Nakamura et al.,
2008). After the exposure period the fish were dissected and bioconcentrations were measured,
with results showing higher bioconcentrations at the higher pH levels (Nakamura et al., 2008).
The researchers concluded that the level of pH in the water affected the ionization of the drug,
and thus affected the bioconcentration in the fish (Nakamura et al., 2008). This result is similar
to other results found by Mennigen et al. (2011), showing long half-lives of fluoxetine even at
varying pH levels. This shows that fluoxetine is highly sensitive to changes in pH, and this
knowledge could prove useful in finding more ways to break it down or reduce the
bioavailability before it enters the environment (Nakamura et al., 2008; Mennigen et al., 2011).
Clearly fluoxetine’s long half-life poses a problem for smaller species when considering
bioconcentration (Mennigen et al., 2011; Brooks et al., 2005). As the drug concentration
increases in the surface water, the potential increases for bioconcentration turning into
bioaccumulation, where the drug buildup in the animal’s tissue may exceed 5000 times the
surrounding water concentration (Nakamura et al., 2008). With the drug building up in the
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animal’s system it is possible to reach toxicity levels and result in death for certain species
(Brooks et al., 2005). However, as the drug accumulates in the animal’s system it has been
shown to cause behavioral changes in these species, which could also contribute to a loss of life
(Margiotta-Casaluci et al., 2014).
Fluoxetine has been shown to have behavioral effects in fathead minnows (Clotfelter et
al., 2007; Fong, Huminski, and D'Urso, 1998; Margiotta-Casaluci et al., 2014). MargiottaCasaluci et al. (2014) studied the effect of fluoxetine on male fathead minnow behavior at six
concentrations: 0.1, 1.0, 8.0, 16, 32, and 64 mg/L. They found that fish exposed to higher
concentrations of the drug displayed bolder behavior, such as more exploration at the top of the
tank than the controls (Margiotta-Casaluci et al., 2014). Furthermore, once the experiment was
over the fish were dissected and norfluoxetine, the major metabolite of fluoxetine, was found in
the fish plasma, meaning the fish were able to metabolize fluoxetine (Margiotta-Casaluci et al.,
2014). This research shows that fish are able to process the drug and that they display bolder
behavior, which could be problematic for predation in the wild (Margiotta-Casaluci et al., 2014).
In addition to showing bolder behavior other research has revealed movement effects
(Eisenreich, Greene, and Szalda-Petree, 2017). If the prey animals are showing bolder behavior
and decreased movement, they could be easily picked off by predators, which could have a major
impact on the prey’s population (Margiotta-Casaluci et al., 2014; Eisenreich, Greene, and
Szalda-Petree, 2017).
The research on the SSRI fluoxetine has shown many different behavioral effects, but
these effects are species dependent with some species showing increases in certain behaviors and
decreases in others (Fong, Huminski, and D'Urso, 1998). The potential range of effects is
concerning when considering the spike in prescriptions used to treat anxiety and depression,
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which will only add more pollutants to the environment (Mackul'Ak et al., 2016). The research
on the effect of fluoxetine is likely to increase, providing more information on behavioral effects
and the potential environmental consequences.
Fluoxetine and Betta splendens
Since fluoxetine has been shown to impact aggression, movement, and reproduction in
fish, the Betta fish or Siamese fighting fish (Betta splendens) is a useful model to use in studying
the effects of fluoxetine on behavior (Abate, 2005; Bronstein, 1989; Hollis et al., 1984; Hogan,
1967; Eisenreich, Greene, and Szalda-Petree, 2017; Goldstein, 1975). Male bettas are highly
aggressive and are responsible for building the nest, attracting the female, obtaining the territory,
and raising the young so their aggressive ability is necessary for reproduction (Hogan, 1967;
Hollis et al., 1984; Dzieweczynski et al., 2005). This makes them and ideal candidate to study
the effect of fluoxetine on movement and aggression.
Early work with Betta splendens focused on defining the aggressive response of the fish
with a focus on the relationship with associative conditioning processes (Hogan, 1967; Hollis et
al., 1984). This research identified specific behaviors associated with courting and fighting
among male fish (Hogan, 1967; Goldstein, 1975; Hollis et al., 1984; Bronstein, 1989). The male
fish are territorial and will attack any male who enters their territory (Hogan, 1967; Goldstein,
1975; Hollis et al., 1984; Bronstein, 1989). This territorial response stems from the reproductive
responsibility of the male fish (Hogan, 1967; Goldstein, 1975; Hollis et al., 1984; Bronstein,
1989). Male fish are responsible for obtaining a territory, building a nest, attracting a female, and
raising the young alone (Hogan, 1967; Goldstein, 1975; Hollis et al., 1984; Bronstein, 1989).
This places selective pressure on the males of the species to have a strong aggressive reaction to
other male fish, and occasionally females if the male is occupied raising fry (Hogan, 1967;
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Goldstein, 1975; Hollis et al., 1984; Bronstein, 1989). In addition to live conspecifics, the male
fish will also respond to a mirror suggesting that the fish do not demonstrate self-recognition
(Hogan, 1967). This fighting response is so strong learning research with males yielded results
revealing that these encounters could be used to reinforce a male fish (Hogan, 1967; Goldstein,
1975; Hollis et al., 1984; Bronstein, 1989). Therefore, the fighting behavior is important to the
reproduction of this species (Hogan, 1967; Goldstein, 1975; Hollis et al., 1984; Bronstein, 1989).
The behaviors the fish used for fighting and courting were analyzed, and four primary
behaviors were identified: biting, lateral displays, gill flaring, and fin spreading (Hogan, 1967;
Goldstein, 1975; Hollis et al., 1984; Bronstein, 1989). These four behaviors make up the primary
signaling behavior exuded by males in response to other males or females (Hogan, 1967;
Goldstein, 1975; Hollis et al., 1984; Bronstein, 1989).When fighting other males often they start
with the low risk behaviors such as lateral displays, gill flaring, and fin spreading to try and
intimidate the opponent and scare them off (Matos et al., 2003; Goldstein, 1975). If these
behaviors do not scare off the rival then they will move toward higher risk behaviors like biting
that could lead to injury or death (Matos et al., 2003; Goldstein, 1975). The length of time it
takes for the fish to engage in the first bite in an encounter is largely dependent on the amount of
area where the fight takes place (Abate, 2005; Goldstein, 1975). Research on latency to first bite
in aggressive encounters with this species found that the time was reduced in smaller tanks when
compared to larger tanks (Abate, 2005; Goldstein, 1975). The contextual cues and available
space are important in an aggressive encounter between males (Hogan, 1967; Goldstein, 1975;
Hollis et al., 1984; Bronstein, 1989).
The earlier work also examined the effect the presence of a female had on aggressive
encounters between males (Goldstein, 1975; Bronstein, 1989). These studies found male bettas
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tend to scale back aggressive behaviors when a female is present, likely due to the male’s larger
size and ability to kill the female if the male is too aggressive (Goldstein, 1975; Bronstein,
1989). This allows the female fish to be used as a prime to provide motivation for the male to
aggress against the mirror even though the priming effect is short for this species and only lasts
about 5 minutes (Bronstein, 1989; Matos et al., 2003). When primed with a female male fish
have been found to use more intimidation behaviors like lateral displays, gill flaring, and fin
spreading (Bronstein, 1989; Matos et al., 2003). However, when males are primed with another
male the latency to the first bite in a subsequent encounter decreases (Bronstein, 1989; Matos et
al., 2003). This shows the importance of the sex of the fish used for priming on risk taking when
motivating the male to engage in an aggressive encounter with another male.
Due to the large amount of literature detailing their behavior Betta splendens have
become one of the common models used to study the impacts of drugs like fluoxetine on
behavior (Hogan, 1967; Goldstein, 1975; Hollis et al., 1984; Bronstein, 1989; Dzieweczynski
and Hebert, 2012; Forsatkar et al., 2014; Eisenreich and Szalda-Petree, 2015; Eisenreich, Greene,
and Szalda-Petree, 2017). The large amount of background information detailing the behaviors
of betta males is helpful when comparing males exposed to different chemicals.
Research with Betta splendens continues to focus on behavioral learning and drug
impacts on learning (Hogan, 1967; Goldstein, 1975; Hollis et al., 1984; Bronstein, 1989;
Dzieweczynski and Hebert, 2012; Forsatkar et al., 2014; Eisenreich and Szalda-Petree, 2015;
Eisenreich, Greene, and Szalda-Petree, 2017). In addition to learning, research examining
behavioral consistency, or predictability, and movement has increased due to the nature of the
drug effects on this species. Many studies have revealed negative impacts of fluoxetine on the
latency to engage in aggressive responding of Betta splendens. In contrast, other studies have
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shown positive effects in terms of increases in behavioral consistency. Therefore, exactly what
change is occurring and how the drug is affecting the motivation to aggress is not largely
explored.
To investigate how the drug affects Betta splendens Clotfelter et al, (2007) analyzed the
brains of the fish to determine the effect antidepressants have on the amount of serotonin found
in fish forebrains. Clotfelter et al. (2007) used mirrors to test the effects of 4.3 nmol fluoxetine
on the aggressive display behavior of the fish before dissecting the fish and analyzing their
brains for the concentration of the drug. Unlike other studies that have administered the drug to
the fish via water absorption, Clotfelter et al. (2007) administered the drug intramuscularly in the
fish. While no significant behavioral changes were detected from exposure to the drug, the fish
in the group injected with the drug had lower levels of serotonin present in their forebrains when
compared to the control subjects (Clotfelter et al., 2007). This suggests that the fish brains are
impacted by the drug, and while no behavioral effects were found at this concentration, other
studies using different dosing methods have found such effects (Clotfelter et al., 2007;
Eisenreich, Greene, and Szalda-Petree, 2017; Eisenreich and Szalda-Petree, 2015).
Past research in our laboratory has explored the effects of the drug on both latency
behavior and aggression (Eisenreich, Greene, and Szalda-Petree, 2017; Eisenreich and SzaldaPetree, 2015). In both studies the male fish were exposed to the fluoxetine several hours before
being tested in an alleyway maze. The male fish were studied using a Go/No Go task where the
latency was measured for the fish to swim from the start box to the goal box containing either a
mirror or no mirror. Once the fish reached the goal box for the mirror the aggressive behavior
was recorded as either yes, the fish responded aggressively, or no, the fish did not respond
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aggressively. Both studies found increased latencies and decreased aggressive responding against
a mirror.
While both studies found significant behavioral effects when the fish were exposed to
fluoxetine, the concentration used was higher than that used in other studies (Dzieweczynski et
al., 2005; Snekser et al., 2006). This higher concentration makes parceling out the behavioral
effects of reduced motivation from motor suppression difficult. Therefore, changes were made in
an effort to manipulate the males and increase their motivation to aggress.
Such experimental preparations lack a key contextual motivation for aggressive
responding – a female betta (Dzieweczynski et al., 2005). Males are aggressive to attract the
female and without one present the motivation to act aggressively toward potential rivals could
be impacted negatively (Goldstein, 1975). Having a female present would help simulate a more
natural context, and potentially increase the motivation of the males to chase off a rival and build
a nest (Dzieweczynski and Hebert, 2012;). This increased motivation may result in more intense
fighting behavior or increase the length of time the male responds to the mirror. Furthermore,
little research has been conducted on the effect of fluoxetine on the interaction between a male
and female fish. Past research has found a negative impact of fluoxetine on aggression, so it is
likely that the interaction with female fish would also be affected since courting and fighting
behaviors are similar. Therefore, determining the effects of both female conspecifics and
fluoxetine is important when studying the motivation of male Betta splendens aggressive
behaviors.
Betta splendens are a useful behavioral model to study the effects of fluoxetine on
aggression and movement. While other studies have been instrumental in exploring the impact of
the drug on the fish behavior there are still several questions left unanswered. The impact of the
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female on male motivation when exposed to the drug is still largely unknown. Could the females
increase the motivation of the males to fight and override the effects reported by the drug? Will
the drug also impact the male’s motivation to court with the female? How long does it take for
the subject’s behavior to return to baseline, if it is even possible to return to baseline at all?
These are some of the unknowns this project hopes to address.
Laboratory Tests for Bioaccumulation
Previous experiments conducted in our laboratory have examined the effects of
fluoxetine on male betta aggression measured using the latency to aggress against a male
conspecific or mirror. The most recent experiments have introduced a female prime to increase
the motivation of the male fish to respond aggressively toward the mirror. While the most recent
study produced interesting results, some changes have been included in the present experiment to
create a more natural context to study the potential drug effects.
The first experiment with the female prime used a between-subjects design where
subjects were assigned to one of four groups: No Female Prime/No Fluoxetine, Female Prime/No
Fluoxetine, No Female Prime/Fluoxetine, and Female Prime/Fluoxetine. This experiment used a
Go/No Go task with a focus on the drug effects on latency and aggressive responding. The fish
were primed for 30 seconds before each trial with either a female or empty container.
The results of the experiment showed an increase in aggressive responding in the males
primed with a female when compared with the males that were not primed. In addition, the males
in the groups exposed to the drug had decreased aggressive responding when compared with the
males not exposed to the drug. No significant results were found for the latency behavior or
mirror preference ratio.
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The present experiment was designed to increase statistical power and create a more
natural motivational context to study the aggressive behavior of Betta splendens. The first major
change is in the experimental design itself. A within-subjects repeated-measures ABA design
was used in place of the previously used between-subjects design. The ABA design, also called a
reversal design, is typically more statistically powerful than the between-subjects design because
subjects serve as their own control. In the ABA design the return to baseline allows for casual
conclusions to be drawn about the effects of fluoxetine on aggressive responding.
The second major change was a modification of the female prime procedure. The male
betta was allowed to view a female betta each day before the start of daily trials for 3 minutes
rather than 30 seconds before each trial. Compared to the previous experiments, this allows more
time for the exposure to the female (female prime) while potentially decreasing potential
distraction during the daily trials.
The last major change was to include detailed behavioral observations of typical
aggressive behaviors in the mirror encounters. Previous experiments from our laboratory have
focused on the negative impacts of fluoxetine on movement and aggressive responding.
However, these experiments lack a detailed analysis of fighting behavior that videos provide.
The proposed experiment used digital recording methods to allow for more detailed analysis of
individual fighting and to reduce potential experimenter bias. The use of videos allowed the
results to analyze the potential negative effects on different aspects of the fighting behavior and
discern if some behaviors experienced a higher impact.
The present experiment examined the effects of fluoxetine and the presence of a female
betta (female prime) on male betta aggressive responding and the latency to aggress using a
Go/No-Go task. It is hypothesized that:
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Latency Effects
1. All fish will have a higher preference ratio for the mirror compared to the non-mirror
presentation regardless of group or condition.
2. The female primed group will have lower latencies to enter the goal box with the mirror
compared to the non-primed group.
3. Subjects will have longer latencies to enter the goal box with the mirror under the
fluoxetine condition compared to the non-fluoxetine conditions.
4. There will be a Prime X Condition interaction such that the female prime group will
show a smaller increase in mirror latency than the non-primed group when exposed to
fluoxetine.
Behavioral Effects
1. The female primed group will exhibit more fighting behavior toward the mirror compared
to the non-primed group.
2. Subjects will exhibit less fighting behavior toward the mirror under the fluoxetine
condition compared to the non-fluoxetine conditions.
3. There will be an increase in the total amount of bites, and time lateral displaying, gill
flaring, and fin spreading between the female primed and non-primed group.
4. There will be a decrease in the total amount of bites, and time lateral displaying, gill
flaring, and fin spreading between the fluoxetine condition and non-fluoxetine conditions.
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Methods

Participants
Twenty-six male and nine female Betta splendens were obtained from Live Aquaria and
were approximately five cm long with red and blue coloration. All fish were housed individually
and maintained on a 12 hr dark/light cycle with tank water temperatures maintained at 76-82 ᵒF.
Material/Apparatus
Individual tanks were approximately 67 cm x 40 cm x 18 cm (L x W x H), containing
approximately 20 liters of water treated with water conditioner to remove chlorine. Each tank
also contained brown gravel, a T-maze, a heater, a thermometer, and a bubbler hooked up to an
airstone. The alleyway maze, in which the fish lived, measured approximately 53 cm x 20 cm x
10 cm (L x W x H). The fish were maintained on a diet of Tetra min betta pellets and received
about eight pellets a day.
A stock solution of 0.5 mmol was created using the SSRI fluoxetine, obtained from TCI
America or Sigma Aldrich. The fish were exposed to the stock solution by mixing 4 ml of the
stock solution with 196 ml of the tank water from each individual fish tank in a separate dosing
chamber, resulting in a 10 μmol concentration of fluoxetine.
Procedure
Male subjects were screened for aggression and matched on latency to aggress toward a
mirror. Matched sets of fish were randomly assigned to two groups: Female Prime (FP) and NoFemale Prime (NFP). FP subjects were exposed to a female prior to the start of trials each day,
while NFP subjects were exposed to an empty chamber before the start of trials each day. The
experiment featured three conditions: baseline, fluoxetine exposure, and return to baseline. Each
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condition continued until the fish showed consistent responding over five consecutive days but
did not exceed 25 days.
The daily testing consisted of 10 trials, with five trials involving the mirror condition and
the other five involving the timeout condition. During the drug condition fish were exposed to
fluoxetine three hours before the beginning of each daily testing session with fish in the non-drug
condition using the same procedure without the drug. The fluoxetine exposure consisted of
placing the fish in a dosing container with 196 ml of their own tank water and 4 ml of the
fluoxetine solution for thirty minutes, resulting in a 10 μmol concentration of fluoxetine. In the
FP group a female conspecific was placed into a clear holding chamber directly adjacent to the
start box before the start of daily trials for three minutes (see Figure 1). In the NFP group fish
were exposed to an empty holding chamber for three minutes before trials started. Once the
three-minute exposure elapsed the view of the holding chamber was blocked with a white wall
and trials began. A unique discriminative stimulus pattern was associated with each reward
condition (mirror or timeout). The mirror or timeout conditions were counterbalanced across
days such that the mirror condition is presented first every other day.
The format for the trials consisted of placing the fish into the start box and then raising
the dividing door between the start box and the holding box for three minutes (see Figure 1). The
courting behavior exhibited by the fish was recorded as either courting occurred or courting did
not occur. After three minutes the dividing door between the start box and the holding box was
lowered and the door between the start box and alleyway was raised. The latency for the fish to
swim into the goal box of the alleyway was recorded. The fighting behavior of the fish was
recorded as either aggressive responding was present or aggressive responding was not present.
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After the 30 seconds of exposure to the mirror had elapsed, the fish were moved back to and
locked in the start box for 30 seconds, after which the next latency trial began.
Female
Holding Box

Male Exposure
Chamber/ Start Box

Alleyway

Goal Box

Mirror or
White Wall

Discriminative
Stimulus

Guillotine Doors

Figure 1. Diagram of the testing apparatus depicting the alleyway maze.
Behavioral observation
During the last five days of data collection in each condition the fish were randomly
assigned a day and their mirror trials were recorded with a camera. Video recordings were coded
using four separate behaviors: fin spreading, lateral displaying, gill flaring, and biting. Fin
spreading was defined as the fish spreading their fins outward from the body. Lateral Displaying
was defined as the fish facing parallel to the mirror with their nose facing the wall and their body
presented to the mirror in either the left or right direction. Gill flaring was defined as spreading
the gills out from the body along the face. Finally, biting was defined as mouth contact with the
mirror with each time the mouth contacts the mirror as one bite. Coders were trained to code
these behaviors until 80 percent interrater reliability was reached.
Analysis
Tests of normality conducted on the data revealed several violations of normality and
skewed distributions. Histograms are presented below in Figure 2 for the three parametric tests
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that had the highest reports of abnormality. Nonparametric tests (Friedman’s ANOVA and
Mann-Whitney U) were conducted in parallel to parametric tests. The hypothesis decisions from
the nonparametric tests did not differ from the parametric tests. As such, parametric tests are
reported for the experiment.

Figure 2. This histogram represents the abnormal biting, gill flaring, and fin spreading data
distribution for the drug (B) phase of the experiment. Tests of normality for Kolmogorov-
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Smirnova conducted on the biting behavior revealed a significant violation of normality of data
((26)= 0.539, p> 0.001), the gill flaring behavior revealed a significant violation of normality of
data ((26)= 0.368, p> 0.001), and the fin spreading behavior revealed a significant violation of
normality of data ((26)= 0.348, p> 0.001).
Data was analyzed using a two (group) X three (condition) Mixed ANOVA. The
Greenhouse-Geisser correction was used for all parametric tests reported. The data for analysis
included latency to enter the goal box for both mirror and non-mirror trials, preference ratio for
the mirror/non-mirror condition, the presence of fighting behavior (Yes or No), and the coding
for the four behaviors. Group means were calculated for each condition and averaged across the
last five testing days for analysis. To calculate the average for the fight behavior in the latency
trial the fish were scored each trial as 0 for fighting behavior not present and 1 for fighting
behavior present. The biting, lateral displays, gill flaring, and fin spreading were scored for each
individual trial by recording the number of bites and the time spent lateral displaying, gill flaring,
and fin spreading. The preference ratio was calculated by dividing the non-mirror latency by the
sum of the non-mirror and mirror latencies for that day (S-/(S-+S+)) which yields a ratio bound
between 0 and 1 with a higher ratio indicating a higher preference for the mirror.
Results
Latency Effects
A one-sample t-test, using a Bonferroni correction for alpha of 0.0166 (.05/3), conducted
on the mirror preference ratio (Latency hypothesis 1) for each condition revealed a nonsignificant effect for the baseline condition (t(25)= 2.042, p= 0.052, d= 0.401), a non-significant
effect for the fluoxetine condition (t(25)= -2.515, p= 0.019, d= 0.494), and a non-significant
effect for return to baseline condition (t(25)= 1.236 p= 0.228, d= 0.242). The mirror preference
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ratio is calculated by dividing the non-mirror latency by the sum of the non-mirror and mirror
latencies for that day (S-/(S-+S+)) which yields a ratio bound between 0 and 1 with a higher ratio
indicating a higher preference for the mirror. See Table 1 for descriptive statistics.
Table 1. One-sample t-test descriptive statistics for the mirror preference ratio averaged across
the last 5 days of testing.
Baseline
Drug
Return to Baseline

Mean
SD
N

0.56
0.14
26

0.48
0.04
26

0.53
0.13
26

A two (groups) X three (conditions) Mixed ANOVA conducted on the latency to enter
the goal box for the mirror condition (Latency hypotheses 2, 3, and 4) revealed a non-significant
main effect for group (F(1,24)= 0.048, p= 0.828, ηp2= 0.002), a significant main effect for
condition (F(1.95, 46.801)= 47.567, p< 0.001, ηp2= 0.665), and a non-significant Group X
Condition interaction (F(1.95, 46.801)= 0.994, p=0.376, ηp2= 0.04). See Table 2 and Figure 3 for
descriptive statistics.
Pairwise comparisons conducted on the three conditions (Latency hypothesis 3) revealed
a significant difference between the baseline and drug condition (t(25)= -9.452, p< 0.001, d=
1.85), a significant difference between the drug condition and return to baseline condition (t(25)=
7.799, p< 0.001, d= 1.53), and no significant difference between the baseline and return to
baseline condition (t(25)= -1.174, p= 0.251, d= 0.23). The mirror raw latency was significantly
longer in the drug condition compared to both baseline conditions.
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Table 2. Group X Drug Condition descriptive statistics for the mirror raw latency (secs) data
averaged across the last 5 days of testing.
Baseline
Drug
Return to Baseline

No Female
Prime
Female Prime

Mean
SD
N

51.33
35.00
13

134.05
17.62
13

63.00
48.05
13

Mean
SD
N

62.31
48.24
13

123.90
38.59
13

70.42
41.94
13

Mirror Latency
160.00

Latency (Seconds)

140.00
120.00
100.00
80.00
60.00
40.00
20.00
0.00
Baseline
No Female Prime

Drug

Return to Baseline

Female Prime

Figure 3. Group X Drug Condition for the mirror raw latency (secs) averaged across the last 5
days of testing.
Behavioral Effects
A two (groups) X three (conditions) Mixed ANOVA conducted on the fight behavior
(Behavioral hypotheses 1 and 2) revealed a non-significant main effect for group (F(1,24)=
0.066, p= 0.799, ηp2= 0.003), a significant main effect for condition (F(1.912, 45.899)= 14.88,
p< 0.001, ηp2= 0.383), and a non-significant Group X Condition interaction (F(1.912, 45.899)=
0.436, p= 0.64, ηp2= 0.018). See Table 3 and Figure 4 for descriptive statistics.
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Pairwise comparisons conducted on the three conditions for the fighting behavior
(Behavioral hypothesis 2) revealed a significant difference between the baseline and drug
condition (t(25)= 5.424, p< 0.001, d= 1.06), a significant difference between the drug condition
and return to baseline condition (t(25)= -3.754, p= 0.001, d= 0.74), and no significant difference
between the baseline and return to baseline condition (t(25)= 1.218, p= 0.235, d= 0.24). The
fighting behavior was significantly lower in the drug condition compared to both baseline
conditions.
Table 3. Group X Drug Condition descriptive statistics for the fight behavior averaged across
the last 5 days of testing.
Baseline
Drug
Return to Baseline

No Female
Prime
Female Prime

Mean
SD
N

0.55
0.36
13

0.12
0.21
13

0.43
0.44
13

Mean
SD
N

0.51
0.38
13

0.22
0.32
13

0.47
0.39
13

Average Fight Behavior

Fight Average
1.00
0.90
0.80
0.70
0.60
0.50
0.40
0.30
0.20
0.10
0.00
Baseline

Drug
No Female Prime

Female Prime

Return to Baseline
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Figure 4. Group X Drug Condition for the fight behavior averaged across the last 5 days of
testing.
A two (groups) X three (conditions) Mixed ANOVA conducted on the biting behavior
(Behavioral hypotheses 3 and 4) revealed a non-significant main effect for group (F(1,22)=
0.619, p= 0.44, ηp2= 0.027), a non-significant main effect for condition (F(1.678, 36.908)=
0.792, p= 0.44, ηp2= 0.035), and a non-significant Group X Condition interaction (F(1.678,
36.908)= 0.309, p= 0.697, ηp2= 0.014). Two outliers were removed from the final analysis. See
Table 4 and Figure 5 for descriptive statistics.
Table 4. Group X Drug Condition descriptive statistics for the biting behavior averaged across
the last 5 days of testing.
Baseline
Drug
Return to Baseline

No Female
Prime
Female Prime

Mean
SD
N

0.02
0.06
11

0.00
0.00
11

0.02
0.06
11

Mean
SD
N

0.02
0.06
13

0.02
0.06
13

0.05
0.12
13

Average Amount

Bites
0.10
0.09
0.08
0.07
0.06
0.05
0.04
0.03
0.02
0.01
0.00
Baseline

Drug
No Female Prime

Female Prime

Return to Baseline
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Figure 5. Group X Drug Condition for the biting behavior averaged across the last 5 days of
testing.
A two (groups) X three (conditions) Mixed ANOVA conducted on the lateral display
behavior (Behavioral hypotheses 3 and 4) revealed a non-significant main effect for group
(F(1,24)= 0.165, p= 0.688, ηp2= 0.007), a significant main effect for condition (F(1.884,
45.213)= 3.874, p= 0.03, ηp2= 0.139), and a non-significant Group X Condition interaction
(F(1.884, 45.213)= 0.427, p= 0.643, ηp2= 0.017). See Table 5 and Figure 6 for descriptive
statistics.
Pairwise comparisons conducted on the three conditions for the lateral display behavior
(Behavioral hypothesis 4) revealed a significant difference between the baseline and drug
condition (t(25)= 2.107, p= 0.045, d= 0.41), a significant difference between the drug condition
and return to baseline condition (t(25)= -2.452, p= 0.022, d= 0.48), and no significant difference
between the baseline and return to baseline condition (t(25)= -0.388, p= 0.701, d= 0.08). The
lateral display behavior was significantly lower in the drug condition compared to both baseline
conditions.
Table 5. Group X Drug Condition descriptive statistics for the lateral display behavior (secs)
averaged across the last 5 days of testing.
Baseline
Drug
Return to Baseline

No Female
Prime
Female Prime

Mean
SD
N

6.35
9.04
13

2.18
2.96
13

7.06
9.59
13

Mean
SD
N

6.78
7.94
13

4.62
4.44
13

7.02
6.95
13
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Lateral Displays

Average (Seconds)

14.00
12.00
10.00
8.00
6.00
4.00
2.00
0.00
Baseline
No Female Prime

Drug

Return to Baseline

Female Prime

Figure 6. Group X Drug Condition for the lateral display behavior (secs) averaged across the last
5 days of testing.
A two (groups) X three (conditions) Mixed ANOVA conducted on the gill flaring
behavior (Behavioral hypotheses 3 and 4) revealed a non-significant main effect for group
(F(1,24)= 0.002, p= 0.966, ηp2< 0.001), a significant main effect for condition (F(1.565,
37.554)= 7.232, p= 0.004, ηp2= 0.232), and a non-significant Group X Condition interaction
(F(1.565, 37.554)= 0.005, p= 0.985, ηp2< 0.001). See Table 6 and Figure 7 for descriptive
statistics.
Pairwise comparisons conducted on the three conditions for the gill flaring behavior
(Behavioral hypothesis 4) revealed a significant difference between the baseline and drug
condition (t(25)= 3.384, p= 0.002, d= 0.66), a significant difference between the drug condition
and return to baseline condition (t(25)= -2.455, p= 0.021, d= 0.48), and no significant difference
between the baseline and return to baseline condition (t(25)= 1.313, p= 0.201, d= 0.26). The gill
flaring behavior was significantly lower in the drug condition compared to both baseline
conditions.
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Table 6. Group X Drug Condition descriptive statistics for the gill flaring behavior (secs)
averaged across the last 5 days of testing.
Baseline
Drug
Return to Baseline

No Female
Prime
Female Prime

Mean
SD
N

4.74
4.49
13

0.72
1.35
13

3.69
4.57
13

Mean
SD
N

4.82
8.25
13

0.68
1.17
13

3.88
7.88
13

Gill Flaring

Average (Seconds)

14.00
12.00
10.00
8.00
6.00
4.00
2.00
0.00
Baseline
No Female Prime

Drug

Return to Baseline

Female Prime

Figure 7. Group X Drug Condition for the gill flaring behavior (secs) averaged across the last 5
days of testing.
A two (groups) X three (conditions) Mixed ANOVA conducted on the fin spreading
behavior (Behavioral hypotheses 3 and 4) revealed a non-significant main effect for group
(F(1,24)= 0.006, p= 0.941, ηp2< 0.001), a significant main effect for condition (F(1.746,
41.905)= 5.102, p= 0.013, ηp2= 0.175), and a non-significant Group X Condition interaction
(F(1.746, 41.905)= 0.757, p= 0.459, ηp2= 0.031). See Table 7 and Figure 8 for descriptive
statistics.
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Pairwise comparisons conducted on the three conditions for the fin spreading behavior
(Behavioral hypothesis 4) revealed a significant difference between the baseline and drug
condition (t(25)= 2.897, p= 0.008, d= 0.57), a significant difference between the drug condition
and return to baseline condition (t(25)= -2.329, p= 0.028, d= 0.46), and no significant difference
between the baseline and return to baseline condition (t(25)= 0.258, p= 0.799, d= 0.05). The fin
spreading behavior was significantly lower in the drug condition compared to both baseline
conditions.
Table 7. Group X Drug Condition descriptive statistics for the fin spreading behavior (secs)
averaged across the last 5 days of testing.
Baseline
Drug
Return to Baseline

No Female
Prime
Female Prime

Mean
SD
N

9.40
9.41
13

1.14
2.72
13

7.14
10.33
13

Mean
SD
N

6.75
8.49
13

3.31
7.38
13

8.14
9.83
13

Fin Spreading

Average (Seconds )

14.00
12.00
10.00
8.00
6.00
4.00
2.00
0.00
Baseline
No Female Prime

Drug
Female Prime

Return to Baseline
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Figure 8. Group X Drug Condition for the fin spreading behavior (secs) averaged across the last
5 days of testing.
Discussion
Of the four latency hypotheses proposed for the latency data only hypothesis three:
subjects will have longer latencies to enter the goal box with the mirror under the fluoxetine
condition compared to the non-fluoxetine conditions, was supported. Latency hypothesis one: all
fish will have a higher preference ratio for the mirror compared to the non-mirror presentation
regardless of group or condition, latency hypothesis two: the female primed group will have
lower latencies to enter the goal box with the mirror compared to the non-primed group, and
latency hypothesis four: there will be a Prime X Condition interaction such that the female prime
group will show a smaller increase in mirror latency than the non-primed group when exposed to
fluoxetine, were not supported.
Failure to support latency hypothesis one is inconsistent with Eisenreich, Greene, and
Szalda-Petree (2017) and Balzarini et al, (2014). Eisenreich, Greene, and Szalda-Petree, (2017)
studied the latencies for fish to aggress against either a mirror or another male conspecific. This
research showed shorter latencies for the excitatory mirror trials than the timeout condition trials
for the fish exposed to a mirror. Fish in the conspecific condition showed longer latencies for the
excitatory fighting trials than the timeout condition trials. The results of this experiment suggest
that the mirror trails were more motivating for the fish than the time-out condition trials.
However, the results of the present experiment do not show a significant preference for the
mirror when the mirror preference ratio is calculated, suggesting the mirror was not significantly
more motivating than the timeout condition.
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The lack of decreased latency for the mirror vs timeout condition could be due to several
factors. The first factor could be the length of time over which the experiment was conducted.
Each fish was exposed daily to the mirror condition for a total of 75 days, with 5 mirror trials a
day yielding a total of 375 mirror trials. The high number of trials completed coupled with the
daily schedule could have led to habituation to the mirror, making it less salient and decreasing
the fish’s motivation to engage in aggressive behavior (Dzieweczynski and Perazio, 2012;
Dzieweczynski, Gill, and Perazio, 2012). A Pearson’s r correlation conducted on the mirror
preference ratio with trial number to test for habituation to the mirror revealed a non-significant
correlation (r(390)= -0.045, p= .378) ruling out habituation as a potential explanation.
In addition to the fish not having a significant preference for the mirror condition, latency
hypothesis two: the female primed group will have lower latencies to enter the goal box with the
mirror compared to the non-primed group, was not supported. This is inconsistent with
Dzieweczynski et al, (2005) and Goldstein (1975), who both found exposure to a female fish led
to increased aggressive responding and motivation in male fish. The present experiment found
the males primed with a female were not significantly more motivated to respond aggressively
toward the mirror when compared with males who were not primed.
Finally, latency hypothesis four: there will be a Prime X Condition interaction such that
the female prime group will show a smaller increase in mirror latency than the non-primed group
when exposed to fluoxetine, was not supported. This is also inconstant with Dzieweczynski et al,
(2005) and Goldstein (1975) who found the males to be more motivated to engage in aggressive
responding when primed with a female. The primed males in the present experiment did not
show decreased latency to aggress toward the mirror when compared to the males who were not
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primed with a female, even when exposed to fluoxetine which impacts the motor and
motivational systems of the fish.
The effects of the prime could have contributed to the motivation and aggression in an
unexpected way inconsistent with the hypothesis’s prediction. The prime lasted a total of three
minutes at the very beginning of the experiment with half of the subjects being primed with a
female and the other half primed with an empty container. The males in the prime condition were
able to court with the females for the full three minutes, while the males who were not primed
with a female would not have had anything to respond to. This would lead to the primed males
already exerting energy to court with the female, while the other males who were not primed
with a female would not have needed to be active. The males who were not primed with a female
would therefore be able to dedicate all their energy to fighting off an opponent, but the males in
the group primed with a female would have to split their responses between the female and the
mirror. This could lead them to become fatigued easier than the males who were not exposed to
the female. This would be consistent with Matos et al. (2003) who found that males primed with
either another male or a female lost more encounters with conspecifics than males who were not
primed.
In addition to losing more encounters with conspecifics other behavioral changes in
fighting style and aggressive responding have been reported by Bronstein (1989) and
Dzieweczynski et al, (2005). These studies found that males primed with other males showed an
increase in risky fighting behaviors such as biting, while males primed with a female decreased
risky behaviors such as biting (Bronstein, 1989; Dzieweczynski et al., 2005). This difference
shows that fighting style is context dependent and that exposure to the female may have
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decreased the aggressive responding in the males primed with a female instead of increasing it as
the hypothesis predicted.
The drug effects are clearly illustrated by the latency results of this experiment, showing
strong support for latency hypothesis three: subjects will have longer latencies to enter the goal
box with the mirror under the fluoxetine condition compared to the non-fluoxetine condition. In
addition to longer latencies for the mirror trials, the non-mirror trials also showed a significant
increase in latency. A two (groups) X three (conditions) Mixed ANOVA conducted on the
latency to enter the goal box for the non-mirror condition revealed a significant main effect for
condition (F(1.540, 36.949)= 60.80, p< 0.001, ηp2= 0.717). Pairwise comparisons conducted on
the three conditions for the non-mirror raw latency revealed a significant difference between the
baseline and drug condition (t(25)= -8.531, p< 0.001, d= 1.67), a significant difference between
the drug condition and return to baseline condition (t(25)= 8.771, p< 0.001, d= 1.72), and no
significant difference between the baseline and return to baseline condition (t(25)= -0.781, p=
0.442, d= 0.15). The non-mirror raw latency was significantly higher in the drug condition
compared to both baseline conditions.
These results support the drug’s effect on movement as well as motivation proposed by
Eisenreich, Greene, and Szalda-Petree (2017). Eisenreich, Greene, and Szalda-Petree (2017)
placed the fish in a small chamber and used a grid system to track the movement of the fish
throughout the small chamber. There was significantly less movement when the fish were
exposed to the drug when compared to the baseline condition. The effect size reported by
Eisenreich, Greene, and Szalda-Petree (2017) for the mirror latency was large, ω2 = 0.4105, and
is reinforced by the results of the current study. Therefore, if the drug is having a negative effect

FISH ON FLUOXETINE

38

on the fish’s ability to move it would be expected that the fish would struggle with the nonmirror trials as well as the mirror trials.
The latency effects found in this experiment show support for the negative impacts of
fluoxetine on the latency to aggress toward a mirror or swim down for the timeout condition. The
drug has been reported to negatively impact the behavior of betta fish in other research studies
such as Eisenreich and Szalda-Petree (2015), and Eisenreich, Greene, and Szalda-Petree (2017).
That effect has been illustrated here using the ABA method of taking a baseline before and after
drug exposure. The impact on the latency was significantly higher for the drug condition,
providing support for the negative impacts of fluoxetine on both movement and motivation.
However, the female prime effects on latency were not significant and did not appear to have an
impact on the latency behavior of the fish. Overall, while the latency behavior is clearly
impacted by exposure to the drug, the latency predictions for the female prime did not support
the hypotheses.
Of the four behavioral hypotheses only hypothesis two: subjects will exhibit less fighting
behavior toward the mirror under the fluoxetine condition compared to the non-fluoxetine
conditions, and hypothesis four: there will be a difference in the total amount of bites, and time
lateral displaying, gill flaring, and fin spreading between the fluoxetine condition and nonfluoxetine conditions, were supported. Behavioral hypothesis one: the female primed group will
exhibit more aggressive behavior toward the mirror compared to the non-primed group, and
behavioral hypothesis three: there will be a difference in the total amount of bites, and time
lateral displaying, gill flaring, and fin spreading between the female primed and non-primed
group, were not supported.
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Failure to support behavioral hypotheses one and three is inconsistent with
Dzieweczynski et al. (2005) who found males were more aggressive when a female was present
when compared to males that did not see a female. Dzieweczynski et al. (2005) concluded that
the males were more aggressive due to the added motivation of attracting a mate and impressing
the female. However, the results of Matos et al. (2003) suggest the opposite to be true; that males
primed with a female will exhibit less risky behaviors, but still maintain aggression. Matos et al.
(2003) found an increase in biting behavior in fights with males who were not primed with a
female, but significantly less biting by males primed with a female. Matos et al. (2003) proposed
that this was because the behaviors exhibited for fighting are similar to the behaviors used in
courting, but risky behaviors such as biting are used to chase off a rival and are less attractive to
a female. Therefore, the males primed with a female may exhibit a different fighting style than
males who are not primed with a female. The data from this experiment did not find a significant
difference in biting, lateral displays, gill flaring, or fin spreading between the female primed
males and males not primed with a female.
While the female prime did not have any significant effect on the aggressive behavior of
the males, the drug did show significant results. Behavioral hypotheses two and four were
supported by the data, showing a negative impact of the drug on the overall aggressive
responding of the fish and on the lateral display, gill flaring, and fin spreading behaviors. A
significant impact was found on the aggressive responding behavior of the fish, with far less
aggressive responding recorded during the drug condition when compared with the baseline and
return to baseline conditions. While the overall aggressive response was lowered, three
individual behaviors were significantly impacted by the drug: lateral displays, gill flaring, and fin
spreading. Only biting was not statistically significantly impacted by the drug, and the effect size
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was smaller. Overall, the drug is impacting certain aspects of the aggressive response, but not
others.
The general effects of the drug on aggressive responding has also been found by
Eisenreich and Szalda-Petree (2015), Eisenreich, Greene, and Szalda-Petree (2017), and
Dzieweczynski and Hebert (2012). These studies have reported negative impacts of fluoxetine on
aggressive behavior and movement of Betta splendens. The present experiment supports these
findings and dissects the fighting behavior into individual behaviors to examine what behaviors
are more susceptible to the drug’s effect. While the biting behavior did not show any significant
impacts from the drug; lateral displaying, gill flaring, and fin spreading did show significant
effects and higher effect sizes. The present findings continue to support the evidence that
fluoxetine has a negative impact on movement and motivation in Betta splendens.
There was one unexpected finding not hypothesized before data collection; that the male
courting behavior was negatively impacted by the drug. The courting behavior was measured as
either 1, male courting behavior occurred, or 0, no male courting behavior occurred, similar to
the way the fighting behavior was measured. An ANOVA conducted on the courting behavior
revealed a significant condition effect (F(1.379, 16.553)= 16.935, p< 0.001, ηp2= 0.585).
Pairwise comparisons conducted on the three conditions for the courting behavior revealed a
significant difference between the baseline and drug condition (t(12)= 4.466, p= 0.001, d= 1.24),
a significant difference between the drug condition and return to baseline condition (t(12)= 4.170, p= 0.001, d= 1.16), and no significant difference between the baseline and return to
baseline condition (t(12)= 1.806, p= 0.096, d= 0.5). The courting behavior was significantly
lower in the drug condition compared to both baseline conditions.

FISH ON FLUOXETINE

41

The courting behavior results parallel those found for the fighting behavior and a
Pearson’s r conducted on the courting and fighting behaviors for the female primed group
revealed a significant positive correlation (r(39)= 0.652, p< 0.001).The present aggression and
courting results support the finding by Dzieweczynski and Hebert (2012) who showed a
significant impact on both the fighting and courting behavior of Betta splendens when exposed to
fluoxetine. This finding provides more support for the impact of fluoxetine on both the
motivation and movement systems in the fish as the drug impacted both the courting and fighting
behavior. While the behaviors used for fighting and courting are similar, one is used to chase off
a rival and the other to attract a mate. However, the male was impacted negatively for both
fighting and courting, making their likelihood of breeding success decrease if this concentration
of the drug is encountered in the wild. The drug’s impact on the motivation to mate would be
devastating if it were to reach similar concentrations in the wild and could have unknown
consequences on the environment.
A number of potential limitations of the present experiment should be addressed in future
studies. The first limitation addresses the amount of motivation and energy a male fish possesses.
Matos et al. (2003) found males that were primed lost more aggressive encounters suggesting the
males have a limited supply of energy they can use for courting and fighting. Since only one
group of males was primed with the female, it is likely that they would have less energy to fight
than the group not primed with the female and lose more of their aggressive encounters. In
addition to exerting more energy attempting to attract the female, the males in the primed group
may have been more distracted by the presence of the female, making them less likely to focus
solely on fighting off their opponent. Therefore, the males in the female prime group would have
to split their attention between fighting and courting, while the males in the group not primed
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with a female would not have to focus on courting. This split of attention could make it more
difficult for the female primed males to win their aggressive encounters and increase their
latencies to enter the goal box.
Another potential problem with the current study is the method of drug administration.
For this experiment the drug was administered to the fish for 30 minutes daily in an isolated
chamber. This method has been used in other studies as well, such as Eisenreich and SzaldaPetree (2015), but it is not the only method used for drug exposure. Dzieweczynski and Hebert
(2012) added the drug directly into the tank water of the fish which created a varying
concentration more reminiscent of fish living in the wild. Even though the studies used different
exposure methods for the drug, they found similar results on behavioral effects. What both
studies are missing, however, is the amount of the drug absorbed by the fish and the
concentration in the animal’s body tissue. Both studies were able to measure the concentration in
the water the fish lived in but had no data to show how much of the drug was absorbed and
metabolized by the subject. This study also does not have data to show overall concentration in
the tissue of the fish throughout the experiment. Collecting the tissue of the animal’s is difficult,
and little is known about the fish’s metabolism and ability to uptake the drug. The overall uptake
in this experiment has the potential for high variability considering the fish uptake the drug
through their skin and gills from the surrounding water, unlike a fixed dose through an injection.
The best way to collect the tissue would be to liquify the body of the fish to find the overall
concentration in the body, which would have to be done at the end of the drug phase and would
not allow for the return to baseline data. This experiment focused on behavioral data and if it was
possible for the fish to recover their baseline behavior after the drug has been purged from their
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system. Since the return to baseline data was needed, there was no attempt to try and obtain drug
concentration data from the subject’s tissue.
Despite the potential flaws in this experiment it still has practical implications. The
steadily increasing concentration and long half-life of fluoxetine are problematic for the
environment when considering the results of this study (Mackul'Ak et al., 2016; Mennigen et al.,
2011). The fish in this study had impacts on both courting and fighting behavior, which will
make reproduction and territory acquisition difficult in the wild. If the fish are unable to
reproduce and maintain their population, this could have impacts on the ecosystem around them.
In addition to the effects on courting and fighting the fish also had increased latencies to swim,
supporting the hypothesis that fluoxetine negatively effects the movement of the fish. This could
make both catching prey and avoiding predation difficult for the fish and further endanger their
species. Clearly the drug is causing major life impairments in this smaller species of fish, and
this study only explores the impact of the drug over a short time-period, 25 days. Other studies
have examined exposure of small fish, clams, and mussels to concentrations of the drug over
longer periods of time and found that the bioconcentration, or buildup of the drug in the animal’s
system due to prolonged exposure, can reach bioaccumulation, where the concentration in the
animal’s system is 5000 percent higher than the surrounding water (Wang and Gardinali, 2013;
De Solla et al., 2016). While the concentration used in the current experiment is higher than
reported environmental concentrations, it is not unreasonable for the organism’s body to reach
this concentration through bioaccumulation. Therefore, the effects seen in this experiment could
start to occur in specimens in the wild if the drug concentration continues its steady increase.
If the drug concentration continues to increase, Betta splendens will not be the only
organisms affected. Other studies have found a wide range of effects on various species, such as
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toxic effects in algae, reproductive changes in clams, and changes in feeding behavior in
minnows (Minguez et al., 2014; Brooks et al., 2003; Fong, Huminski, and D'Urso, 1998;
Margiotta-Casaluci et al., 2014). Smaller species will be the first ones affected, creating an issue
that will stem from a bottom-up approach. Due to the aquatic animal’s smaller size and constant
exposure to the drug through their environment they will be at risk for experiencing the most
harmful effects and will likely experience the negative change first. Once the smaller species
begin to experience the harmful effects larger species that depend on them will also be affected,
through lack of food or change in habitat. In addition, if the smaller species of fish are prey
animals and have reached bioaccumulation the predator animal will be ingesting a higher amount
of the drug through consumption of the smaller creature. Overall, the impact on the environment
could be devasting if nothing is done to prevent chemical pollution from continuing to increase.
While this paints a bleak picture for the future there is hope. If efforts are put forth to
combat the increase in chemicals in the waterways, there is a chance to once again allow the
animals to recover their normal behavior. As seen with the present experiment the fish recovered
their baseline behavior after 25 days once the drug was removed. This suggests that the effects of
the drug can be reversible and may not be permanent. However, there currently is not an
economically efficient way to remove the chemicals, and current methods using nanoparticles as
traps can cause more problems later on (Koçolu, Bakirdere, and Keyf, 2017; Basheer, 2018). The
clock is ticking, but the countdown may have already begun.
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